Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

TK inhibitors under development at Dr. Karl Thomae

Nov. 13, 1997

Sankyo synthesizes azole aromatase inhibitors

Nov. 13, 1997

Mitsui Toatsu reveals novel antitumor agents

Nov. 12, 1997

Radicicol derivatives with antitumor activity from Sankyo

Nov. 12, 1997

MDR-reversing agents reported by Nikken Chemicals

Nov. 12, 1997

Spotlight on topoisomerase I inhibitors

Nov. 12, 1997

DepoCyt to be reviewed by FDA advisory committee this month

Nov. 11, 1997

NCI supports R&D on antiangiogenic agents at Telios

Nov. 10, 1997

New taxoids from RPR

Nov. 10, 1997

Gensia Sicor terminates collaboration with Atrix

Nov. 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...